Pádraig O'Sullivan
Ceist:132. Deputy Pádraig O'Sullivan asked the Minister for Health further to Parliamentary Question No. 158 of 22 May 2024, when the HSE executive management team will be in a position to approve or make a decision on the reimbursement application for dostarlimab (jemperli) indicated as monotherapy for the treatment of adult patients with recurrent or advance endometrial cancer; and if he will make a statement on the matter. [25807/24]
Amharc ar fhreagra